Biotech Inve$t, Tuesday 19 March 2019


Organiser’s welcome Remarks

Joe Zhou

Chair’s opening Remarks

Joe Zhou, Chief Executive Officer, Genor BioPharma, Walvax Group

Opening Keynote Plenary

David Lane

Going global and keeping it local: Is biotech innovation sustainable in Asia?

In this keynote presentation, Sir David Lane, one of the key scientists credited on the discovery of cancer gene p53, a gene which mutation cause near 50% of all human cancer, will share his view on how biomedical sciences have developed in Singapore, Japan and the remaining APAC region, and prospects for Asian biotech and pharma industry.
Byung-Geon Rhee

Looking east: Integrating Asia into the global era of innovative medicine

Panel discussion

Pharma Trends: Women health as the next focus

By 2023, it is estimated that the women’s health market will be worth $37.4 billion. But despite this impressive growth, across the world there are still significant unmet needs in the space. In this panel discussion, we will explore the significant opportunities in the women’s health market, from drug discovery and development to effective clinical trials and ensuring access to treatment, including both strategy development and technology advances.
Nilesh Wadhwa

Driving innovation forward: The Johnson & Johnson perspective

Fostering innovation is a big challenge, so what’s the recipe for success? In this session, learn about how Johnson & Johnson Innovation is helping to accelerate life sciences innovation and how its Asia Pacific team is creating new opportunities for emerging biotech and pharma businesses. Nilesh will share insights into Johnson & Johnson’s unique model for addressing the major challenges in local innovation ecosystems, and how new collaborations are helping transform the trajectory of human health.

Exhibition visit & networking refreshments

Carrie Hillyard
Biotech Inve$t

Chair's opening remarks

Petcha Kucha
Biotech Inve$t

Biotech Pitch

10 minutes per company
Ken Taylor, Chief Executive Officer, Living Cell Technologies Limited
Poh Loong Soong, Co-Founder, Ternion Biosciences Pte. Ltd

Exhibition Visit & Networking Lunch


Exhibition Visit & Networking Refreshments

Panel discussion

Networking Cocktail & End of Conference Day 1

last published: 18/Mar/19 14:05

Biotech Inve$t, Wednesday 20 March 2019


Organiser’s welcome Remarks


Chairman’s opening Remarks

Nadia Suttikulpanich

Disrupt before being disrupted: Using digital tech to connect to previously uneconomic chronic disease customers

Insurance is a tricky part of healthcare business. Increased healthcare costs lead to a higher profit for pharma and provider companies but burdens the government budget and hurts the insurance business. Since taking care of a chronic patient is a lifelong commitment, the availability of insurance to cover this essential treatment is often expensive and uneconomical. Join Nadia Suttikulpanich, Head of the Fuchsia Innovation Center, part of Muang Thai Life Assurance, Thailand as she shares how they are adopting digital tech to pilot chronic disease cover to provide for patients in need while keeping their insurance business profitable.
Edward Rosen

The path to personalised medicine: Key developments

Everyone knows the potential benefits of personalised medicine, but how do we get there? Finding and better defining disease through biomarkers and more accurate diagnostics. Targeted therapeutics to leverage new and emerging diagnostic capabilities. Personalized Medicine to Real-Time Medicine. How to drive success across industry and clinical implementation in an economic manner. This presentation discusses various strategies and key considerations to drive the symbiosis between academia, industry and clinical medicine to drive vastly improved patient outcomes.

Roundtable discussion

Table 1 Working with clinical outsourcing partners: Risk management and prevention

Table 2 Fostering commercial partnerships to tap on emerging APAC markets

Table 3 Regulatory collaboration and opportunities in more efficient drug development

Table 4 - Enhancing patient engagement in clinical trials

Table 5 - Futureproofing the workforce and leveraging the sharing economy in your business

Table 6 - Precision to personalised medecine: How do we get there?

Table 7 - Outsourcing your injectable: Benefit from an experienced CDMO partner


Exhibition Visit & Networking Refreshments

Anthony Desir
Biotech Inve$t

Funding risk & return strategies: Investor & investee perspectives

Biotech Inve$t

Networking lunch & exhibition visit


Exhibition Visit & Networking Lunch


End of Phar-East 2019

last published: 18/Mar/19 14:05






For speaking, sponsorship and exhibition opportunities contact
Tel: +65 6322 2738